Multimin Solution for Injection for Cattle
Multimin Solution for Injection for Cattle
Authorised
- Zinc oxide
- Manganese carbonate
- Copper(II) carbonate
- Sodium selenite
Product identification
Medicine name:
Multimin Solution for Injection for Cattle
Multimin ενέσιμο διάλυμα για βοοειδή
Active substance:
- Zinc oxide
- Manganese carbonate
- Copper(II) carbonate
- Sodium selenite
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Zinc oxide74.68milligram(s)1.00millilitre(s)
-
Manganese carbonate20.92milligram(s)1.00millilitre(s)
-
Copper(II) carbonate26.09milligram(s)1.00millilitre(s)
-
Sodium selenite10.95milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Meat and offal28day
-
Milk0hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12CX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap. Package sizes: Cardboard box containing one vial of 500 ml
- Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap. Package sizes: Cardboard box containing one vial of 100 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Warburton Technology Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratoires Biové
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 59186/ 25-06-2021 (K-0246901)
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0322/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Denmark
-
Estonia
-
Finland
-
France
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 26/05/2022
How useful was this page?: